Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale 10% owner sold 4,550,357 shares at $17.06 ($77,606,339)
  3. 4 Grant or award Director acquired 2,317 shares (grant or award)
  4. 4 Exercise or conversion EVP, General Counsel acquired 7,467 shares (option exercise)
  5. 4 Shares withheld for taxes Director gave up 33,714 shares (to pay taxes)
  6. 4 Exercise or conversion President, U.S. Businesses acquired 22,235 shares (option exercise)
  7. 4 Exercise or conversion Chief Executive Officer acquired 32,022 shares (option exercise)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale 10% owner sold 35,000,000 shares at $17.06 ($596,925,000)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Shares withheld for taxes SVP, Controller and CAO gave up 747 shares (to pay taxes)
  14. 4 Open-market sale U.S. President-Pharma Business sold 1,595 shares at $22.19 ($35,393)
  15. 4 Grant or award Director acquired 300 shares (grant or award)
  16. 4 Grant or award Director acquired 1,668 shares (grant or award)
  17. 4 Grant or award Director acquired 1,340 shares (grant or award)
  18. 4 Grant or award Director acquired 1,340 shares (grant or award)
  19. 4 Grant or award Director acquired 1,504 shares (grant or award)
  20. 4 Grant or award Director acquired 1,340 shares (grant or award)

Page 11 of 61 · 1,214 filings